Source: Genomeweb

Roswell Biotechnologies: Roswell Biotechnologies Provides Details on Molecular Electronics Device in Proof-of-Concept Study

Researchers said the paper had "impressive" results but that the technology still needs to prove itself with low target concentrations and complex samples.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Paul Mola's photo - President & CEO of Roswell Biotechnologies

President & CEO

Paul Mola

CEO Approval Rating

70/100

Read more